| Financial Year |
March 31 2023 |
| Monetary Funds |
76,954,867.30 |
| Held-for-trading Financial Assets |
708,998.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
20,170,819.81 |
| Advances to Suppliers |
6,766,876.41 |
| Other Receivables |
2,289,613.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,488,685.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
216,379,861.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
958,122,834.76 |
| Under-construction Projects |
95,404,431.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
113,281,560.85 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,295,949.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,965,616.32 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
20,267,951.34 |
| Sub-Total of Non-Current Assets |
1,268,965,013.77 |
| Total Assets |
1,485,344,875.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
95,698,068.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,988,477.79 |
| Taxes Payable |
742,887.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,431,502.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
85,319,914.28 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
277,428,841.74 |
| Long-term Loans |
395,449,404.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,950,387.20 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
419,990,688.43 |
| Total Liabilities |
697,419,530.17 |
| Paid-In Capital(Or Share Stock) |
190,211,500.00 |
| Capital Surplus |
307,340,010.57 |
| Surplus Reserve |
43,002,477.95 |
| LESS:Treasury Stock |
31,086,195.00 |
| Undistributed Profits |
278,457,551.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
787,925,345.42 |
| Owner's Equity（Stockholder's Equity） |
787,925,345.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,485,344,875.59 |
